[ad_1]
Washington, United States:
President Donald Trump on Tuesday introduced a $1.5 billion contract with US biotech firm Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May.
“I’m pleased to announce that we have reached an agreement with Moderna to manufacture and deliver 100 million doses of their coronavirus vaccine candidate,” Trump stated at a White House information convention. “The federal government will own these vaccine doses, we’re buying them.”
“We’re on track to rapidly produce 100 million doses as soon as the vaccine is approved, and up to 500 million shortly thereafter, so we’ll have 600 million doses,” he added.
Moderna, in partnership with the US National Institutes of Health (NIH), is conducting Phase three medical trials of a vaccine candidate and manufacturing of vaccine doses will happen whereas the trials are underway.
The vaccine, referred to as mRNA-1273, is being co-developed by Moderna and the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), which is led by Dr Anthony Fauci.
Fauci has stated researchers are unlikely to know the efficacy of the vaccine earlier than the tip of the 12 months on the earliest. But Trump has stated he hopes to have a vaccine earlier than the November three presidential election.
The newest contract brings the US authorities’s complete commitments to Moderna to $2.48 billion.
The firm, based lower than 10 years in the past, has not beforehand developed a vaccine of any variety however preliminary outcomes of the corporate’s experimental COVID-19 vaccine have reportedly produced promising outcomes.
The Trump administration has allotted a complete of no less than $10.9 billion for the event and manufacturing of a coronavirus vaccine.
It has already ordered 100 million vaccine doses from Johnson & Johnson, Novavax, Pfizer and Sanofi and 300 million from AstraZeneca.
(This story has not been edited by NDTV employees and is auto-generated from a syndicated feed.)
[ad_2]
Source hyperlink